PKU Market Poised for 8.1% CAGR Through 2032
Phenylketonuria (PKU) Market 2026: Strategic Preview for Corporate Decision‑Makers Executive snapshot Phenylketonuria (PKU) is transitioning from a narrowly defined rare-disease marketplace into a dynamically evolving specialty therapy ecosystem. Our PW Consulting market model — grounded in a 2020–2025 historical base … Read more